Concepedia

Yoichi Inada

YI

13

Publications

543

Citations

12

H-Index

1991

Active since

Affiliations

Kissei Pharmaceutical (Japan)(Current)

Shinshu University

Shinshu University Hospital

University of Tsukuba

Yoichi Inada is an author at Kissei Pharmaceutical (Japan) specializing in medicine, physiology, and pharmacology.

Top concepts

Publications per year

1991–2021

13

Publications

13

Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet

Tatsuya Nagasawa, Yoichi Inada, Shigeru Nakano et al. · European Journal of Pharmacology · 2006 · 228 citations

, , +9

Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4

Junichi Shoda, Yoichi Inada, Atsutoshi Tsuji et al. · Journal of Lipid Research · 2004 · 55 citations · Full text

Bezafibrate regulates the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes

Shigeru Nakano, Yoichi Inada, Hiroaki Masuzaki et al. · American Journal of Physiology-Endocrinology and Metabolism · 2006 · 41 citations

, , +20

Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor‐β1 in a cultured stellate cell line

Shigeru Nakano, Tatsuya Nagasawa, Tomoyuki Ijiro et al. · Hepatology Research · 2008 · 38 citations

CHARACTERIZATION OF CYTOCHROME P450 EXPRESSION IN MURINE EMBRYONIC STEM CELL-DERIVED HEPATIC TISSUE SYSTEM

Masaru Tsutsui, Shinichiro Ogawa, Yoichi Inada et al. · Drug Metabolism and Disposition · 2006 · 36 citations

Rows per page

1–5 of 13